Robert Goldberg
Hematology & Oncology · New City, NYNPI 1780628362
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.1%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Dova Pharmaceuticals at 54.0% of the total.
Across 124 payments — averaging $45.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dova Pharmaceuticals$3K
- Tosoh Bioscience, Inc.$427
- Johnson & Johnson$278
- Amgen$240
- Genentech USA, Inc.$236
- AstraZeneca$125
- plus $1K from 25 others
What the payments were for
- Consulting fees$2,80050%
- Travel & lodging$1933%
- Food & beverage$2,00336%
- Education$1653%
- Gifts$4278%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dova Pharmaceuticals | 3 | $3,015 |
| Tosoh Bioscience, Inc. | 1 | $427 |
| Johnson & Johnson(2 entities) | 25 | $278 |
| Amgen | 8 | $240 |
| Genentech USA, Inc. | 10 | $236 |
| AstraZeneca | 8 | $125 |
| Sanofi | 7 | $119 |
| Bayer | 4 | $110 |
| Lilly USA, LLC | 5 | $98 |
| Pfizer | 5 | $80 |
| Seagen Inc. | 5 | $72 |
| Novartis | 3 | $67 |
| Incyte Corporation | 3 | $65 |
| Merck | 4 | $64 |
| Boehringer Ingelheim | 3 | $61 |
| Eisai Inc. | 3 | $57 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $50 |
| Bristol Myers Squibb | 3 | $49 |
| Verastem, Inc. | 2 | $46 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $41 |
| Kyowa Kirin, Inc. | 2 | $39 |
| Taiho Oncology, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Gilead | 2 | $32 |
| AbbVie | 2 | $31 |
| EMD Serono, Inc. | 2 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Bio Products Laboratory USA, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Rigel Pharmaceuticals, Inc. | 1 | $15 |
| Tesaro, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DOPTELET$2,993
- CEA, ST, AIA-PACK$427
- CEA, AIA-PACK Calibrator Set$427
- CEA, AIA-PACK Linearity Set$427
- CEA, AIA-PACK Sample Diluting Solution$427
- EXHAUST DUCT PROTECTOR$427
How this compares
$5,588 in reported general payments places this provider in the 65th percentile of 967 hematology & oncology providers in New York.
Other hematology & oncology in New City
- Michael SchusterNew York$1.6M
- Charles SawyersNew York$1.6M
- Manuel Hidalgo-MedinaNew York$1.4M
- Francis ArenaLake Success$1M
- Sanjeev JainEast Patchogue$971K
- Ross LevineNew York$968K
- Perry CookBrooklyn$803K
- Mihir RavalAlbany$767K
- Joshua SabariNew York$761K
- Gail RobozNew York$738K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.